Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women with candidiases infection | Women that are prescribed treatment with clotrimazole: 500 mg. and probiotics (routine clinical practice) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Estimate cure rate in women with severe vuvovaginal candidiases infection | Women must require antimicotic treatment plus vaginal probiotic following the habitual therapeutic standards | At 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Estimate recurrences | It will be consider recurrences an asymptomatic period for 7-10 days and a negative culture | At 6 months |
| Estimate recurrences | It will be consider recurrences an asymptomatic period for 7-10 days and a negative culture |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Women with VVC symptomatology and positive culture
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Santiago Palacios, PI | Instituto Palacios | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Instituto Palacios | Madrid | 28009 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002177 | Candidiasis |
| D014627 | Vaginitis |
| ID | Term |
|---|---|
| D009181 | Mycoses |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D014623 | Vaginal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| At 12 months |
| Evaluate the link between symptomatology and negative culture | At 3 months |
| Evaluate the effectiveness of probiotic treatment by physician | A gynecological exploration will be performed | At 3 months |
| Evaluate the effectiveness of probiotic treatment by patient. A satisfaction questionnaire will be performed | The subject will be asked how long the symptoms lasted and the gravity of them | At 3 months |
| D005831 |
| Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |